(12) United States Patent (10) Patent No.: US 9,603,883 B2 Huang Et Al

(12) United States Patent (10) Patent No.: US 9,603,883 B2 Huang Et Al

USOO96.03883B2 (12) United States Patent (10) Patent No.: US 9,603,883 B2 Huang et al. (45) Date of Patent: *Mar. 28, 2017 (54) METHODS OF INHIBITING A BACTERIAL (56) References Cited VIRULENCE IN A SUBJECT U.S. PATENT DOCUMENTS (71) Applicant: LiveLeaf, Inc., San Carlos, CA (US) 1844,018 A 2f1932 Sailer (72) Inventors: Alexander L. Huang, Menlo Park, CA 1,891,149 A 12/1932 Elger (US); Gin Wu, San Rafael, CA (US) (Continued) (73) Assignee: LIVELEAF, INC., San Carlos, CA FOREIGN PATENT DOCUMENTS (US) CN 1079.393 12/1993 CN 1922.996 3, 2007 (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 (Continued) U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS This patent is Subject to a terminal dis claimer. U.S. Appl. No. 61/009,484. Huang,et al.—related case Publicly available in Application 2013/0078322, Dec. 28, 2007. (21) Appl. No.: 15/199,075 (Continued) (22) Filed: Jun. 30, 2016 Primary Examiner — Trevor Love (65) Prior Publication Data (74) Attorney, Agent, or Firm — Brian S. Boyer; US 2016/0310455 A1 Oct. 27, 2016 Syndicated Law, PC Related U.S. Application Data (63) Continuation of application No. 14/745,426, filed on (57) ABSTRACT Jun. 20, 2015, now Pat. No. 9,408,869, which is a Methods of inhibiting bacterial virulence in a subject are (Continued) provided. The methods can include administering an effec tive amount of a formulation to inhibit a bacterial virulence (51) Int. C. in a Subject, the formulation having a water soluble tannin A6 IK 36/22 (2006.01) combined with hydrogen peroxide in a pharmaceutically A6 IK3I/7034 (2006.01) acceptable excipient; wherein, the tannin has a molecular (Continued) weight ranging from about 170 Daltons to about 4000 (52) U.S. C. Daltons; the tannin:peroxide weight ratio ranges from about CPC ............ A61K 36/22 (2013.01); A61K 31/192 1:1000 to about 10:1; and, the composition inhibits a bac (2013.01); A61K 31/352 (2013.01); terial virulence in the Subject when compared to a second (Continued) Subject in a control group in which the composition was not (58) Field of Classification Search administered. CPC ... A61K 36/22: A61K 3 1/7034; A61K 45/06; A61K 31/352: A61K 3 1/7028; (Continued) 28 Claims, 4 Drawing Sheets US 9,603,883 B2 Page 2 Related U.S. Application Data 5,328,706 T/1994 Endico 5,389,369 2, 1995 Allen continuation of application No. 14/662,725, filed on 5,614,501 3, 1997 Richards Mar. 19, 2015, now Pat. No. 9,089,596, which is a 5,653,746 8, 1997 Schmitt 5,661,170 8, 1997 Chodosh continuation of application No. 14/584,419, filed on 5,700,769 12, 1997 Schneider et al. Dec. 29, 2014, now Pat. No. 9,023,895, which is a 5,756,090 5, 1998 Allen continuation of application No. 14/317.970, filed on 5,824.414 10, 1998 Kobayashi et al. Jun. 27, 2014, now Pat. No. 8,946,304, which is a 5,834.409 11, 1998 Ramachandran et al. 5,839,369 11, 1998 Chatterjee et al. continuation of application No. 14/272,047, filed on 5,879,733 3, 1999 Ekanayake et al. May 7, 2014, now Pat. No. 8,809,399, which is a 5,891.440 4, 1999 Lansky continuation of application No. 14/222,605, filed on 6,068,862 5/2000 Ishihara et al. Mar. 22, 2014, now Pat. No. 8,772,352, which is a 6,071,541 6, 2000 Murad continuation of application No. 14/173,079, filed on 6,080,573 6, 2000 Convents et al. 6,136,849 10, 2000 Hoffmann et al. Feb. 5, 2014, now Pat. No. 8,772,350, which is a 6,284,770 9, 2001 Mangel et al. continuation of application No. 14/142.895, filed on 6,296,880 10, 2001 Murad Dec. 29, 2013, now Pat. No. 8,716,353, which is a 6,297.273 10, 2001 Romanczyk, Jr. continuation of application No. 13/726, 180, filed on 6,383,523 5/2002 Murad Dec. 23, 2012, now Pat. No. 8,716,351. 6,420,148 T/2002 Yamaguchi 6,436,342 8, 2002 Petri et al. 6,444,805 9, 2002 Sohn et al. (51) Int. C. 6,537,546 3, 2003 Echigo et al. A6 IK 45/06 (2006.01) 6,551,602 4/2003 Barrett et al. A6 IK3I/352 (2006.01) 6,630,163 10, 2003 Murad A6 IK3I/7028 (2006.01) 6,642.277 11/2003 Howard et al. 6,926,881 8, 2005 Hirose et al. A6 IK 36/82 (2006.01) 6,936,580 8, 2005 Sherry et al. A6 IK3I/7048 (2006.01) 7,018,660 3, 2006 Murad A6 IK3I/353 (2006.01) 7.241,461 7/2007 Myhill et al. A6 IK3I/92 (2006.01) 7,297,344 11/2007 Fleischer et al. A6 IK3I/I-85 (2006.01) 7,341,744 3, 2008 Rozhon et al. 7,504,251 3, 2009 Olshenitsky et al. A6 IK 33/40 (2006.01) 7.972,632 T/2011 Jia A6 IK 36/185 (2006.01) 8,007,771 8, 2011 Ramji et al. (52) U.S. C. 8,067,041 11/2011 Quart et al. CPC ........ A6 IK3I/353 (2013.01); A61 K3I/7028 8,343,552 1, 2013 Huang et al. 8,586,110 11/2013 Huang et al. (2013.01); A61 K3I/7034 (2013.01); A61 K 8,716,351 5, 2014 Huang et al. 3 1/7048 (2013.01); A61K 33/40 (2013.01); 8,716.352 5, 2014 Huang et al. A61K 36/185 (2013.01); A61K 36/82 8,716.353 5, 2014 Huang et al. (2013.01); A61K 45/06 (2013.01) 8,722,040 5, 2014 Huang et al. Field of Classification Search 8,722,116 5, 2014 Huang et al. (58) 8,734,867 5, 2014 Huang et al. CPC ... A61K 36/82: A61K 31/7048: A61K 31/353; 8,765,818 T/2014 Huang et al. A61K 31/192: A61K 36/185; A61K 33/40 8,772,350 T/2014 Huang et al. See application file for complete search history. 8,772,351 T/2014 Huang et al. 8,772,352 T/2014 Huang et al. References Cited 8,790,640 T/2014 Huang et al. (56) 8,809,399 8, 2014 Huang et al. 8,822,544 9, 2014 Huang et al. U.S. PATENT DOCUMENTS 8,822,545 9, 2014 Huang et al. 8,916,539 12/2014 Yedgar et al. 1965,458 A T. 1934 Elger 8,946,304 2, 2015 Huang et al. 3,484.248 A 12, 1969 Graham et al. 8,952,072 2, 2015 Huang et al. 3,649,297 A 3, 1972 Millin 9,023,895 5/2015 Huang et al. 3,692.904 A 9, 1972 Tsutsumi 9,089,596 7/2015 Huang et al. 3,817,835 A 6, 1974 Neidleman 9,192,635 11/2015 Huang et al. 3,821,440 A 6, 1974 Reeve 9.408,869 8, 2016 Huang et al. 3,824, 184 A 7, 1974 Hatcher et al. 2001/OOOTT62 T/2001 Echigo et al. 3,860,694 A 1/1975 Jayawant 2002fOO34553 3, 2002 Zayas 3,864.454. A 2, 1975 Pistor et al. 2002fOO41901 4, 2002 Murad 4,008,339 A 2, 1977 Matsuda et al. 2002/0172719 11/2002 Murad 4,072,671 A 2, 1978 Sodini et al. 2003/0059396 3, 2003 Bhakoo et al. 4,171,280 A 10, 1979 Maddox et al. 2003/0078212 4/2003 Li et al. 4,435,601 A 3, 1984 Formanek et al. 2003/0228.379 12, 2003 Shi et al. 4472.302 A 9, 1984 Karkhanis 2004/OO 13710 1, 2004 Howell 4472,602 A 9, 1984 Bordelon et al. 2004/0022863 2, 2004 Hamtini 4,514,334 A 4, 1985 Mark 2004/O137.077 T/2004 Ancira et al. 4,623,465. A 11, 1986 Klibanov 4,829,001 A 5, 1989 Mencke et al. 2004/0228831 11/2004 Belinka, Jr. et al. 4,900,671 A 2, 1990 Pokora et al. 2005, 0169988 8, 2005 Tao et al. 4,966,762 A 10, 1990 Pfeffer et al. 2005/0175658 8, 2005 DiMauro et al. 5,008,248 A 4, 1991 Bywater et al. 2006, OO24339 2, 2006 Murad 5,141,611 A 8, 1992 Ford 2006, OO24385 2, 2006 Pedersen 5,208,010 A 5, 1993 Thaler 2006/0051429 3, 2006 Murad 5,231,193 A 7, 1993 Mizusawa et al. 2006/0105069 5/2006 Moffett et al. 5,260,021 A 11, 1993 Zeleznick 2006, O165812 T/2006 Charron 5,296,376 A 3, 1994 Bridges et al. 2006/0292255 12, 2006 Moffett et al. US 9,603,883 B2 Page 3 (56) References Cited U.S. Appl. No. 14/304.812, Huang,et al.—related case, Jun. 13, 2014. U.S. PATENT DOCUMENTS U.S. Appl. No. 15/270,491, Huang,et al.—related case, Dec. 23, 2012. 2007, OO 10632 A1 1/2007 Kaplan et al. European search report for EP 10749 160, Sep. 10, 2013. 2007/0110812 A1 5, 2007 Xia et al. European search report for EP 12802538, Apr. 30, 2014. 2007. O154414 A1 7/2007 Bonfiglio 2007/0178055 A1 8, 2007 Buch et al. European search report for EP 13865735.8, LiveLeaf, Inc.—related 2007/O187429 A1 8, 2007 Farahmand CaSC. 2007/0275104 A1 1 1/2007 Kornman et al.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    31 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us